Literature DB >> 29595710

Cardiovascular Risk Factors as Differential Predictors of Incident Atypical and Typical Major Depressive Disorder in US Adults.

Jay S Patel1, Jessica Berntson, Brittanny M Polanka, Jesse C Stewart.   

Abstract

OBJECTIVE: Although the association between major depressive disorder (MDD) and future cardiovascular disease (CVD) is established, less is known about the relationship between CVD risk factors and future depression, and no studies have examined MDD subtypes. Our objective was to determine whether hypertension, tobacco use, and body mass index (BMI) differentially predict atypical and typical MDD in a national sample of US adults.
METHODS: We examined prospective data from 22,915 adults with no depressive disorder history at baseline who participated in Wave 1 (2001-2002) and Wave 2 (2004-2005) of the National Epidemiologic Survey on Alcohol and Related Conditions. CVD risk factors (Wave 1) and incident MDD subtypes (Wave 2) were determined by structured interviews.
RESULTS: There were 252 patients with atypical MDD and 991 patients with typical MDD. In fully adjusted models, baseline hypertension (odds ratio [OR] = 0.57, 95% confidence interval [CI] = 0.43-0.76), former tobacco use (OR = 1.46, 95% CI = 1.20-1.78), and BMI (OR = 1.32, 95% CI = 1.25-1.40; all p < .001) predicted incident atypical MDD versus no MDD, whereas no CVD risk factor predicted incident typical MDD. Baseline hypertension (OR = 0.52, 95% CI = 0.39-0.70), former tobacco use (OR = 1.53, 95% CI = 1.22-1.93), and BMI (OR = 1.26, 95% CI = 1.18-1.36; all p < .001) also predicted incident atypical MDD versus typical MDD.
CONCLUSIONS: Our study is the first to report that CVD risk factors differentially predict MDD subtypes, with hypertension (protective factor), former tobacco use (risk factor), and BMI (risk factor) being stronger predictors of incident atypical versus typical MDD. Such evidence could provide insights into the etiologies of MDD subtypes and inform interventions tailored to MDD subtype.

Entities:  

Mesh:

Year:  2018        PMID: 29595710      PMCID: PMC6023772          DOI: 10.1097/PSY.0000000000000583

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  41 in total

1.  Cardiovascular-emotional dampening: the relationship between blood pressure and recognition of emotion.

Authors:  James A McCubbin; Marcellus M Merritt; John J Sollers; Michele K Evans; Alan B Zonderman; Richard D Lane; Julian F Thayer
Journal:  Psychosom Med       Date:  2011-10-31       Impact factor: 4.312

Review 2.  Obesity, inflammation, and cardiovascular risk.

Authors:  P Mathieu; I Lemieux; J-P Després
Journal:  Clin Pharmacol Ther       Date:  2010-03-03       Impact factor: 6.875

3.  Elevated IL-6 levels in patients with atypical depression but not in patients with typical depression.

Authors:  Sebastian Rudolf; Wiebke Greggersen; Kai Gustav Kahl; Michael Hüppe; Ulrich Schweiger
Journal:  Psychiatry Res       Date:  2014-02-20       Impact factor: 3.222

Review 4.  Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies.

Authors:  Floriana S Luppino; Leonore M de Wit; Paul F Bouvy; Theo Stijnen; Pim Cuijpers; Brenda W J H Penninx; Frans G Zitman
Journal:  Arch Gen Psychiatry       Date:  2010-03

5.  The association between obesity, depression, and educational attainment in women: the mediating role of body image dissatisfaction.

Authors:  Amelia R Gavin; Greg E Simon; Evette J Ludman
Journal:  J Psychosom Res       Date:  2010-07-03       Impact factor: 3.006

6.  Symptoms of depression prospectively predict poorer self-care in patients with Type 2 diabetes.

Authors:  J S Gonzalez; S A Safren; L M Delahanty; E Cagliero; D J Wexler; J B Meigs; R W Grant
Journal:  Diabet Med       Date:  2008-09       Impact factor: 4.359

Review 7.  The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings.

Authors:  Deborah S Hasin; Bridget F Grant
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-07-26       Impact factor: 4.328

8.  Atypical depressive symptoms and obesity in a national sample of older adults with major depressive disorder.

Authors:  Kee-Lee Chou; Kar-Ming Yu
Journal:  Depress Anxiety       Date:  2013-04-03       Impact factor: 6.505

9.  The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample.

Authors:  Bridget F Grant; Deborah A Dawson; Frederick S Stinson; Patricia S Chou; Ward Kay; Roger Pickering
Journal:  Drug Alcohol Depend       Date:  2003-07-20       Impact factor: 4.492

10.  Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010.

Authors:  Fangjian Guo; Di He; Wei Zhang; R Grace Walton
Journal:  J Am Coll Cardiol       Date:  2012-07-11       Impact factor: 24.094

View more
  3 in total

1.  Associations between depressive symptoms, cigarette smoking, and cardiovascular health: Longitudinal results from CARDIA.

Authors:  Allison J Carroll; Mark D Huffman; Lihui Zhao; David R Jacobs; Jesse C Stewart; Catarina I Kiefe; Wendy Brunner; Kiang Liu; Brian Hitsman
Journal:  J Affect Disord       Date:  2019-09-09       Impact factor: 6.533

2.  Association of Depressive Symptoms With Incident Cardiovascular Diseases in Middle-Aged and Older Chinese Adults.

Authors:  Haibin Li; Deqiang Zheng; Zhiwei Li; Zhiyuan Wu; Wei Feng; Xue Cao; Jiaxin Wang; Qi Gao; Xia Li; Wei Wang; Brian J Hall; Yu-Tao Xiang; Xiuhua Guo
Journal:  JAMA Netw Open       Date:  2019-12-02

3.  Obesity and atypical depression symptoms: findings from Mendelian randomization in two European cohorts.

Authors:  Giorgio Pistis; Yuri Milaneschi; Caroline L Vandeleur; Aurélie M Lasserre; Brenda W J H Penninx; Femke Lamers; Dorret I Boomsma; Jouke-Jan Hottenga; Pedro Marques-Vidal; Peter Vollenweider; Gérard Waeber; Jean-Michel Aubry; Martin Preisig; Zoltán Kutalik
Journal:  Transl Psychiatry       Date:  2021-02-04       Impact factor: 6.222

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.